<?xml version='1.0' encoding='utf-8'?>
<section xmlns="https://code.dccouncil.us/schemas/dc-library" xmlns:codified="https://code.dccouncil.us/schemas/codified" xmlns:codify="https://code.dccouncil.us/schemas/codify" xmlns:xi="http://www.w3.org/2001/XInclude" containing-doc="D.C. Code">
  <num>28-4553</num>
  <heading>Excessive pricing in sales of prescription drugs, a violation of law.</heading>
  <text>It shall be unlawful for any drug manufacturer or licensee thereof, excluding a point of sale retail seller, to sell or supply for sale or impose minimum resale requirements for a patented prescription drug that results in the prescription drug being sold in the District for an excessive price.</text>
  <annotations>
    <annotation doc="D.C. Law 16-37" type="History">Dec. 10, 2005, D.C. Law 16-37, ยง 2, 52 DCR 9061</annotation>
  </annotations>
</section>
